Kim HD et al reported that the tumour-infiltrating CD8+ T cells could be subdivided into PD-1-high, PD-1-intermediate, and PD-1-negative subpopulations with distinct gene expression profiles, different exhaustion-related immunophenotypes, and functional capacities [25]. The gene discussed is CD8A; the disease is neoplasm.